Tennis elbow Musculoskeletal Diseases Tennis elbow, lateral epicondylitis
Conditions
Interventions
The trial participants will be patients with lateral epicondylitis. They will be randomly divided between comparative groups A and B, which will receive TECAR therapy and sham TECAR therapy, respectiv
Sponsors
Academy of Physical Education in Katowice
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Pain in the lateral epicondyle persisting for =3 months 2. Pain on palpation in the lateral epicondyle 3. A positive Thompson’s test (the patient reports pain when performing resisted extension of a slightly extended wrist, with the fingers clenched into a fist, the elbow extended, and the forearm in a pronated position) 4. A positive Mill’s test (the patient reports pain when performing resisted supination of the forearm with the elbow joint slightly flexed, the forearm in a pronated position, the wrist slightly extended, and the fingers clenched into a fist) 5. Pain during resisted extension of the middle finger 6. Aged 18 to 65 years
Exclusion criteria
Exclusion criteria: 1. Local infection 2. Pregnancy 3. Malignancy 4. Bilateral tennis elbow 5. Carpal tunnel syndrome 6. Medial epicondylitis 7. Elbow arthritis or instability 8. Generalized polyarthritis 9. Ipsilateral shoulder dysfunction 10. Neurological abnormalities 11. Radial-nerve entrapment 12. Cardiac arrhythmia or a pacemaker 13. Diabetes 14. Physical therapy and/or a corticosteroid injection administered within the previous six weeks
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Grip strength in the affected and unaffected upper limbs measured by a SH5001 dynamometer (SAEHAN Corporation) at baseline, 1, 6 and 12 weeks 2. Strength of the wrist extensors in the affected and unaffected upper limbs measured by a SH5001 dynamometer (SAEHAN Corporation) at baseline, 1, 6 and 12 weeks 3. Strength of the wrist flexors in the affected and unaffected upper limbs measured by a SH5001 dynamometer (SAEHAN Corporation) at baseline, 1, 6 and 12 weeks 4. Pain intensity during physical activity measured on the Visual Analog Scale 0-10 (VAS) at baseline, 1, 6 and 12 weeks 5. Pain intensity at rest measured on the Visual Analog Scale 0-10 (VAS) at baseline, 1, 6 and 12 weeks 6. Pain intensity at night measured on the Visual Analog Scale 0-10 (VAS) at baseline, 1, 6 and 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Quantitative pain assessment performed with the modified Laitinen’s questionnaire at baseline, 1, 6 and 12 weeks Quantitative pain assessment will be performed pre-treatment and at weeks 1, 6, and 12 post-treatment 2. Pain intensity and difficulty in performing daily activities measured using the Patient-Rated Tennis Elbow Evaluation (PRTEE) at baseline, 1, 6 and 12 weeks 3. The extent of disability of the affected upper limb measured using the Disabilities of the Arm, Shoulder and Hand questionnaire (DASH) at baseline, 1, 6 and 12 weeks 4. Treatment outcomes assessed based on the Roles and Maudsley score (RMS) at 1, 6, and 12 weeks | — |
Countries
Poland
Outcome results
None listed